The Pharmaceutical Care Management Association (PCMA) released the following statement today on the Congressional Budget Office’s (CBO) $43 billion score of point-of-sale rebates in Medicare Part D. Read More »
HHS Secretary Alex Azar issued the following statement regarding the FDA’s approval of the first non-opioid treatment for the symptoms of opioid withdrawal Read More »
In President Trump’s remarks today at the White House, he made clear the essential role that generic and biosimilar medicines play in containing prescription drug costs for patients. Read More »
BIO President and CEO Jim Greenwood issued the following statement after President Trump announced his administration’s plan to lower prescription drug costs: Read More »
“The American Diabetes Association’s new white paper on insulin prices confirms that drugmakers set, and continue to raise, prices. Read More »
“Employers, unions, and state health programs hire pharmacy benefit managers (PBMs) to reduce costs for patients by, among other things, negotiating discounts with drug companies and drugstores. Read More »
Pharmaceutical Care Management Association (PCMA) President and CEO Mark Merritt released the following statement on the House Energy and Commerce Health Subcommittee’s hearing Combating the Opioid Crisis: Read More »
As the independent drugstore lobby descends on Capitol Hill this week to push for costly new government health mandates, the Pharmaceutical Care Management Association (PCMA) continues to highlight how pharmacy benefit managers (PBMs) reduce prescription drug costs and improve benefits for consumers, employers, unions, and public programs. Read More »
The Pharmaceutical Research and Manufacturers of America (PhRMA) held its board meeting, officially welcoming three new elected officers. Read More »
Taxes are lower, ISIS is on the run, and the regulatory agencies are in a ceasefire with the US economy. Read More »
Following President Donald Trump’s recent signing of the Food and Drug Administration Reauthorization Act, Biotechnology Innovation Organization officials released a statement of support celebrating the legislation reauthorizing prescription drug user fees. Read More »
Pharmaceutical Care Management Association (PCMA) President and CEO Mark Merritt has written directly to U.S. Food and Drug Administration Commissioner Scott Gottlieb to offer the association’s concise solution for fast-tracking “common-sense” improvements to the nation’s opioid abuse policy. Read More »
Suggesting ways to reduce prescription drug costs plus overall marketplace guidance, the Pharmaceutical Care Management Association recently wrote to Health and Human Services Secretary Tom Price, detailing potential pricing and savings allocation improvements. Read More »
Novo Nordisk recently announced positive results from its phase 3b Dual VII clinical trial for Xultophy, a product created to treat type 2 diabetes. Read More »
Generic drug makers insist they attempted to work with state legislators in Maryland to carve out a bill to curb "price gouging," but they ignored the advice and passed an unconstitutional law, according to an industry group. Read More »
Pharmaceutical Care Management Association (PCMA) recently announced that it has initiated litigation proceedings in federal court in response to a pair of state laws which it believes jeopardizes patient safety and concurrently increases prescription costs. Read More »
"Drug manufacturers, wholesalers, pharmacies, and insurance companies are just some of the entities that should be involved in finding a true market solution" to drug pricing," writes Dr. Kathleen Iacocca, professor at Villanova University School of Business. "The industry has to change itself to avoid Washington interference and all of those impacted need to be equally involved." Read More »
One in four Americans taking certain prescribed medicines say they would stop taking them immediately—without consulting their doctor—after seeing ads promoting lawsuits against the drugs’ manufacturers, according to a new national survey released by the U.S. Chamber Institute for Legal Reform (ILR). Read More »
Do television ads by plaintiffs' lawyer firms hawking lawsuits over prescription drugs cause patients to cease taking their prescribed prescriptions? Read More »
A new study published in the Journal of the American Medical Association finds that doctors are influenced by gifts and their relationships with drug company representatives. Read More »
Alerts Sign-up